This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Insiders are Scooping Up

>>5 Big Stock Charts You Need to See


One independent oil and gas player that insiders are jumping into here is Endeavour (END). This company is engaged in the production, exploration, development and acquisition of crude oil and natural gas in the U.K. North Sea and U.S. Onshore. Insiders are buying this stock into some notable weakness, since shares are down by 35% in the last three months.

Endeavour has a market cap of $277 million and an enterprise value of $1.03 billion. This stock trades at a cheap valuation, with a forward price-to-earnings of 9.31. Its estimated growth rate for this year is -61%, and for next year it's pegged at 128.6%. This is not a cash-rich company, since the total cash position on its balance sheet is $75.72 million and its total debt is $825.43 million.

A beneficial owner just bought 337,979 shares, or $1.83 million worth of stock, at $5.40 per share.

From a technical perspective, END is currently trending below both its 50-day and 200-day moving averages. This stock has been downtrending badly for the last four months, with shares dropping from $10.48 to its recent low of $4.66 a share. During that downtrend, shares of END have been mostly making lower highs and lower lows, which is bearish technical price action. That said, the stock has recently started to rebound off that $4.66 low and move within range of triggering a near-term breakout trade.

If you're bullish on END, then I would look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $6.22 to $6.61 a share and then once it takes out more overhead resistance levels at $6.91 to $7.19 with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 773,839 shares. If that breakout hits soon, then END will set up to re-test or possibly take out its next major overhead resistance levels at $8 to its 200-day moving average at $8.40 a share.

Synageva BioPharma

Another name in the biopharmaceutical complex that insiders are snapping up here is Synageva BioPharma (GEVA). This company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need. Insiders are buying this stock into some decent strength, since shares are up 19% in the last six months.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
GEVA $238.60 1.19%
END $0.01 -1.33%
LYV $25.61 0.20%
NBY $0.16 5.40%
OMER $15.37 -0.26%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs